[1]
|
Chen, H.J., Wang, C.G., Dou, H.L., et al. (2020) Effect of Intravitreal Ranibizumab Pretreatment on Vitrectomy in Young Patients with Proliferative Diabetic Retinopathy. Annals of Palliative Medicine, 9, 82-89.
https://doi.org/10.21037/apm.2020.01.10
|
[2]
|
中国老年2型糖尿病防治临床指南(2022年版) [J]. 中国糖尿病杂志, 2022, 30(1): 2-51.
|
[3]
|
李筱荣, 杨千惠. 美国眼科学会《糖尿病视网膜病变临床指南》解读[J]. 中华实验眼科杂志, 2020, 38(9): 795-798.
|
[4]
|
刘旭, 王霞, 何媛. 糖尿病视网膜病变危险因素与预防研究进展[J]. 眼科新进展, 2018, 38(7): 687-691.
|
[5]
|
覃水喷. 糖尿病视网膜病变的临床治疗现状及研究进展[J]. 国际医药卫生导报, 2022, 28(8): 1180-1184.
|
[6]
|
祝伟, 苏冠方, 王晨光, 等. 糖尿病视网膜病变的病理机制和新型药物研究进展[J]. 中国老年学杂志, 2013, 33(5): 1207-1210.
|
[7]
|
贺鹏程, 刘昌汶, 尹卫东, 等. 糖尿病性视网膜病中血-视网膜屏障损伤的研究进展[J]. 临床与病理杂志, 2019, 39(5): 1090-1094.
|
[8]
|
Bai, Y., Ma, J.X., Guo, J., et al. (2009) Muller Cell-Derived VEGF Is a Significant Contributor to Retinal Neovascularization. The Journal of Pathology, 219, 446-454. https://doi.org/10.1002/path.2611
|
[9]
|
Feng, S., Yu, H., Yu, Y., et al. (2018) Levels of Inflamma-tory Cytokines IL-1beta, IL-6, IL-8, IL-17A, and TNF-Alpha in Aqueous Humour of Patients with Diabetic Retinopathy. Journal of Diabetes Research, 2018, Article ID: 8546423.
https://doi.org/10.1155/2018/8546423
|
[10]
|
Hammes, H.P. (2018) Diabetic Retinopathy: Hyperglycaemia, Oxida-tive Stress and beyond. Diabetologia, 61, 29-38.
https://doi.org/10.1007/s00125-017-4435-8
|
[11]
|
刘钰, 李乐乐, 桑爱民. 氧化应激在糖尿病视网膜病变发病机制中的作用[J]. 国际眼科纵览, 2022, 46(1): 5-10.
|
[12]
|
Chang, K.C., Snow, A., LaBarbera, D.V., et al. (2015) Aldose Reductase Inhibition Alleviates Hyperglycemic Effects on Human Retinal Pigment Epithelial Cells. Chemi-co-Biological Interactions, 234, 254-260.
https://doi.org/10.1016/j.cbi.2014.10.007
|
[13]
|
Stitt, A.W. (2003) The Role of Advanced Glycation in the Patho-genesis of Diabetic Retinopathy. Experimental and Molecular Pathology, 75, 95-108. https://doi.org/10.1016/S0014-4800(03)00035-2
|
[14]
|
邢薇, 董志军, 张铁民. 糖尿病视网膜病变发病机制的研究进展[J]. 中国实用眼科杂志, 2014, 32(6): 675-678.
|
[15]
|
崔彦, 许迅. 糖尿病性视网膜病变分子机制的研究进展[J]. 眼视光学杂志, 2007, 9(2): 135-138.
|
[16]
|
张凤俊, 李晶明, 刘秋平. 糖尿病视网膜病变发病机制及潜在治疗研究进展[J]. 眼科新进展, 2020, 40(7): 677-685.
|
[17]
|
陈小红, 王云鹏, 陈梅珠. VEGF在糖尿病性视网膜病变发病机制中的作用及抗VEGF治疗新进展[J]. 眼科新进展, 2015, 35(7): 692-696.
|
[18]
|
任洪芹, 朱鸿, 施彩虹. 糖尿病视网膜病变相关炎性细胞因子研究进展[J]. 国际眼科杂志, 2010, 10(4): 697-699.
|
[19]
|
Demircan, N., Saf-ran, B.G., Soylu, M., et al. (2006) Determination of Vitreous Interleukin-1 (IL-1) and Tumour Necrosis Factor (TNF) Levels in Proliferative Diabetic Retinopathy. Eye, 20, 1366-1369.
https://doi.org/10.1038/sj.eye.6702138
|
[20]
|
于宏飞, 董志军, 张铁民. 糖尿病视网膜病变相关炎性因子的研究进展[J]. 中国实用眼科杂志, 2015, 33(7): 713-716.
|
[21]
|
周林, 康建芳, 冯军, 等. 糖尿病视网膜病变患者房水VEGF和IL-6水平的测定及其临床意义[J]. 中国实用眼科杂志, 2011, 29(1): 21-24.
|
[22]
|
Joy, S.S. and Siddiqui, K. (2019) Molecular and Pathophysiological Mechanisms of Diabetic Retinopathy in Relation to Adhesion Molecules. Cur-rent Diabetes Reviews, 15, 363-371.
https://doi.org/10.2174/1573399814666181017103844
|
[23]
|
Zietz, B., Buechler, C., Kobuch, K., et al. (2008) Se-rum Levels of Adiponectin Are Associated with Diabetic Retinopathy and with Adiponectin Gene Mutations in Cauca-sian Patients with Diabetes Mellitus Type 2. Experimental and Clinical Endocrinology & Diabetes, 116, 532-536. https://doi.org/10.1055/s-2008-1058086
|
[24]
|
刘艳, 隋虹, 罗志忠, 等. 糖尿病性视网膜病变与糖尿病控制状态研究[J]. 中国糖尿病杂志, 2002, 10(1): 37-39.
|
[25]
|
Ting, D.S., Cheung, G.C. and Wong, T.Y. (2016) Diabetic Retinopathy: Global Prevalence, Major Risk Factors, Screening Practices and Public Health Challenges: A Review. Clin-ical & Experimental Ophthalmology, 44, 260-277.
https://doi.org/10.1111/ceo.12696
|
[26]
|
Rodriguez-Fontal, M., Kerrison, J.B., Alfaro, D.V. and Jablon, E.P. (2009) Metabolic Control and Diabetic Retinopathy. Current Diabetes Reviews, 5, 3-7. https://doi.org/10.2174/157339909787314176
|
[27]
|
Yoon, Y.H., Boyer, D.S., Maturi, R.K., et al. (2019) Natural History of Diabetic Macular Edema and Factors Predicting Outcomes in Sham-Treated Patients (MEAD Study). Graefe’s Archive for Clinical and Experimental Ophthalmology, 257, 2639-2653. https://doi.org/10.1007/s00417-019-04464-2
|
[28]
|
Lock, J.H. and Fong, K.C.S. (2010) Retinal Laser Photocoagu-lation. Medical Journal of Malaysia, 65, 88-94.
|
[29]
|
高晔, 孙桂波, 罗云, 等. 糖尿病视网膜病的发病机制及药物干预研究进展[J]. 中国药理学通报, 2020, 36(4): 491-495.
|
[30]
|
周爱意, 陈凌, 周陈静, 等. 全视网膜激光光凝治疗高危增生型糖尿病视网膜病变的效果分析[J]. 眼科新进展, 2016, 36(4): 352-355.
|
[31]
|
陈家欣, 吴瑜瑜. 全视网膜光凝术对糖尿病视网膜病变视网膜神经纤维层及黄斑区视网膜的影响[J]. 眼科新进展, 2015, 35(4): 380-383.
|
[32]
|
Chen, H., Pan, X.F., Yang, J.Y., et al. (2021) Application of 5G Technology to Conduct Real-Time Teleretinal Laser Photocoagulation for the Treatment of Diabetic Retinopathy. JAMA Ophthalmology, 139, 975-982.
https://doi.org/10.1001/jamaophthalmol.2021.2312
|
[33]
|
陈娟, 吕红彬. 抗VEGF药物在糖尿病性视网膜病变治疗中的应用[J]. 眼科新进展, 2014, 34(4): 397-400.
|
[34]
|
邓玲, 潘颖喆, 王慧. 糖尿病性视网膜病变的治疗进展[J]. 2020, 20(3): 489-491.
|
[35]
|
Googe, J., Brucker, A.J., Bressler, N.M., et al. (2011) Randomized Trial Evaluating Short-Term Effects of Intravitreal Ranibizumab or Triamcinolone Acetonide on Macular Edema after Focal/Grid Laser for Diabetic Macular Edema in Eyes Also Receiving Panretinal Photocoagulation. Retina, 31, 1009-1027.
https://doi.org/10.1097/IAE.0b013e318217d739
|
[36]
|
Machemer, R., Sugita, G. and Tano, Y. (1979) Treatment of Intraocular Proliferations with Intravitreal Steroids. Transactions of the American Ophthalmological Society, 77, 171-180.
|
[37]
|
Ciardella, A.P., Klancnik, J., Schiff, W., et al. (2004) Intravitreal Triamcinolone for the Treatment of Re-fractory Diabetic Macular Oedema with Hard Exudates: An Optical Coherence Tomography Study. British Journal of Ophthalmology, 88, 1131-1136. https://doi.org/10.1136/bjo.2004.041707
|
[38]
|
He, Y., Ren, X.J., Hu, B.J., et al. (2018) A Meta-Analysis of the Effect of a Dexamethasone Intravitreal Implant versus Intravitreal Anti-Vascular Endothe-lial Growth Factor Treatment for Diabetic Macular Edema. BMC Ophthalmology, 18, Article No. 121. https://doi.org/10.1186/s12886-018-0779-1
|
[39]
|
Ciulla, T.A., Harris, A., McIntyre, N., et al. (2014) Treatment of Diabetic Macular Edema with Sustained-Release Glucocorticoids: Intravitreal Triamcinolone Acetonide, Dexamethasone Implant, and Fluocinolone Acetonide Implant. Expert Opinion on Pharmacotherapy, 15, 953-959. https://doi.org/10.1517/14656566.2014.896899
|
[40]
|
Lin, J., Chang, J.S., Yannuzzi, N.A., et al. (2018) Cost Eval-uation of Early Vitrectomy versus Panretinal Photocoagulation and Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy. Ophthalmology, 125, 1393-1400.
https://doi.org/10.1016/j.ophtha.2018.02.038
|
[41]
|
杨艳风, 程萍, 魏婷. 玻璃体切除联合白内障手术治疗增生性糖尿病视网膜病变的疗效[J]. 国际眼科杂志, 2018, 18(3): 544-546.
|
[42]
|
Al-Khersan, H., Venincasa, M.J., Kloosterboer, A., et al. (2020) Pars Plana Vitrectomy Reoperations for Complications of Proliferative Diabetic Retinopa-thy. Clinical Ophthalmology, 14, 1559-1563.
https://doi.org/10.2147/OPTH.S252285
|
[43]
|
Zhang, Z.H., Liu, H.Y., Hernandez-Da, M.S., et al. (2013) Vitrec-tomy with or without Preoperative Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy: A Meta-Analysis of Randomized Controlled Trials. American Journal of Ophthalmology, 156, 106-115. https://doi.org/10.1016/j.ajo.2013.02.008
|